Overexpression of the secretory small GTPase Rab27B in human breast cancer correlates closely with lymph node metastasis and predicts poor prognosis

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Zhang, Jia Xing ^a   Huang, Xiao Xia ^a   Cai, Man Bo ^b   Tong, Zhu Ting ^c   Chen, Jie Wei ^a   Qian, Dong ^a   Liao, Yi Ji ^a   Deng, Hai Xia ^a   Liao, Ding Zhun ^a   Huang, Ma Yan ^a   Zeng, Yi Xin ^a   Xie, Dan ^a   Mai, Shi Juan ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; EMT; Metastasis; Prognosis; Rab27B

Indexed keywords

GUANOSINE TRIPHOSPHATASE; MESSENGER RNA; PROTEIN RAB27B; SECRETORY PROTEIN; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; BREAST FIBROADENOMA; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EPITHELIAL MESENCHYMAL TRANSITION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; MULTIVARIATE ANALYSIS; PREDICTION; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TISSUE SECTION; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, WESTERN; BREAST NEOPLASMS; COHORT STUDIES; DNA PRIMERS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; PROGNOSIS; RAB GTP-BINDING PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE;

EID: 84870337000     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-242     Document Type: Article

References (35)

1. Yang L, Li LD, Chen YD, Parkin DM. Time trends, estimates and projects for breast cancer incidence and mortality in China. Zhonghua Zhong Liu Za Zhi 2006, 28:438-440.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
3. Bombonati A, Sgroi DC. The molecular pathology of breast cancer progression. J Pathol 2011, 223:307-317. 3069504, 21125683.
4. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96. 10.3322/CA.2007.0010, 18287387.
5. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast RC. American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007, 25:5287-5312. 10.1200/JCO.2007.14.2364, 17954709.
6. Fukuda M. Regulation of secretory vesicle traffic by Rab small GTPases. Cell Mol Life Sci 2008, 65:2801-2813. 10.1007/s00018-008-8351-4, 18726178.
7. Pereira-Leal JB, Seabra MC. Evolution of the Rab family of small GTP-binding proteins. J Mol Biol 2001, 313:889-901. 10.1006/jmbi.2001.5072, 11697911.
8. Zerial M, McBride H. Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2001, 2:107-117. 10.1038/35052055, 11252952.
9. Pfeffer SR. Structural clues to Rab GTPase functional diversity. J Biol Chem 2005, 280:15485-15488. 10.1074/jbc.R500003200, 15746102.
10. Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 2009, 10:513-525.
11. Chen D, Guo J, Miki T, Tachibana M, Gahl WA. Molecular cloning and characterization of rab27a and rab27b, novel human rab proteins shared by melanocytes and platelets. Biochem Mol Med 1997, 60:27-37. 10.1006/bmme.1996.2559, 9066979.
12. Westbroek W, Lambert J, De Schepper S, Kleta R, Van Den Bossche K, Seabra MC, Huizing M, Mommaas M, Naeyaert JM. Rab27b is up-regulated in human Griscelli syndrome type II melanocytes and linked to the actin cytoskeleton via exon F-Myosin Va transcripts. Pigment Cell Res 2004, 17:498-505. 10.1111/j.1600-0749.2004.00173.x, 15357836.
13. Jordens I, Westbroek W, Marsman M, Rocha N, Mommaas M, Huizing M, Lambert J, Naeyaert JM, Neefjes J. Rab7 and Rab27a control two motor protein activities involved in melanosomal transport. Pigment Cell Res 2006, 19:412-423. 10.1111/j.1600-0749.2006.00329.x, 16965270.
14. Westbroek W, Tuchman M, Tinloy B, De Wever O, Vilboux T, Hertz JM, Hasle H, Heilmann C, Helip-Wooley A, Kleta R, Gahl WA. A novel missense mutation (G43S) in the switch I region of Rab27A causing griscelli syndrome. Mol Genet Metab 2008, 94:248-254. 10.1016/j.ymgme.2008.02.009, 2430933, 18397837.
15. Cheng KW, Lahad JP, Kuo WL, Lapuk A, Yamada K, Auersperg N, Liu J, Smith-McCune K, Lu KH, Fishman D, Gray JW, Mills GB. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med 2004, 10:1251-1256. 10.1038/nm1125, 15502842.
16. Kanda I, Nishimura N, Nakatsuji H, Yamamura R, Nakanishi H, Sasaki T. Involvement of Rab13 and JRAB/MICAL-L2 in epithelial cell scattering. Oncogene 2008, 27:1687-1695. 10.1038/sj.onc.1210812, 17891173.
17. Liu YJ, Wang Q, Li W, Huang XH, Zhen MC, Huang SH, Chen LZ, Xue L, Zhang HW. Rab23 is a potential biological target for treating hepatocellular carcinoma. World J Gastroenterol 2007, 13:1010-1017.
18. Hou Q, Wu YH, Grabsch H, Zhu Y, Leong SH, Ganesan K, Cross D, Tan LK, Tao J, Gopalakrishnan V, Tang BL, Kon OL, Tan P. Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer. Cancer Res 2008, 68:4623-4630. 10.1158/0008-5472.CAN-07-5870, 18559507.
19. Fukui K, Tamura S, Wada A, Kamada Y, Igura T, Kiso S, Hayashi N. Expression of Rab5a in hepatocellular carcinoma: possible involvement in epidermal growth factor signaling. Hepatol Res 2007, 37:957-965. 10.1111/j.1872-034X.2007.00143.x, 17581187.
20. Bravo-Cordero JJ, Marrero-Diaz R, Megias D, Genis L, Garcia-Grande A, Garcia MA, Arroyo AG, Montoya MC. MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway. EMBO J 2007, 26:1499-1510. 10.1038/sj.emboj.7601606, 1829373, 17332756.
21. Wang JS, Wang FB, Zhang QG, Shen ZZ, Shao ZM. Enhanced expression of Rab27A gene by breast cancer cells promoting invasiveness and the metastasis potential by secretion of insulin-like growth factor-II. Mol Cancer Res 2008, 6:372-382. 10.1158/1541-7786.MCR-07-0162, 18337447.
22. Chia WJ, Tang BL. Emerging roles for Rab family GTPases in human cancer. Biochim Biophys Acta 2009, 1795:110-116.
23. Hendrix A, Maynard D, Pauwels P, Breams G, Denys H, Van Den Broecke R, Lambert J, Van Belle S, Cocquyt V, Gespach C, Brache M, Seabra MC, Gahl WA, De Wever O, Westbroek W. Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis. J Natl Cancer Inst 2010, 102:866-880. 10.1093/jnci/djq153, 2886092, 20484105.
24. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark GM, Edge SB, Hayes DF, Hughes LL, Hutter RV, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS, Greene FL. Staging system for breast cancer: revisions for the 6th edition of the AJCC cancer staging manual. Surg Clin North Am 2003, 83:803-819. 10.1016/S0039-6109(03)00034-3, 12875597.
25. Yan LX, Wu QN, Zhang Y, Li YY, Liao DZ, Hou JH, Fu J, Zeng MS, Yun JP, Wu QL, Zeng YX, Shao JY. Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast Cancer Res 2011, 13:R2. 10.1186/bcr2803, 3109565, 21219636.
26. Zhang Y, Yan LX, Wu QN, Du ZM, Chen J, Liao DZ, Huang MY, Hou JH, Wu QL, Zeng MS, Huang WL, Zeng YX, Shao JY. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res 2011, 71:3552-3562. 10.1158/0008-5472.CAN-10-2435, 21444677.
27. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008, 14:2348-2360. 10.1261/rna.1034808, 2578865, 18812439.
28. Zlobec I, Steele R, Terracciano L, Jass JR, Lugli A. Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol 2007, 60:1112-1116. 10.1136/jcp.2006.044537, 2014838, 17182662.
29. Dong WW, Mou Q, Chen J, Cui JT, Li WM, Xiao WH. Differential expression of Rab27A/B correlates with clinical outcome in hepatocellular carcinoma. World J Gastroenterol 2012, 18:1806-1813. 10.3748/wjg.v18.i15.1806, 3332295, 22553406.
30. Mignot G, Chalmin F, Ladoire S, Rebe C, Ghiringhelli F. Tumor exosome-mediated MDSC activation. Am J Pathol 2011, 178:1403-1404. author reply 1404-1405, 10.1016/j.ajpath.2010.11.078, 3069877, 21356390.
31. Ochieng J, Pratap S, Khatua AK, Sakwe AM. Anchorage-independent growth of breast carcinoma cells is mediated by serum exosomes. Exp Cell Res 2009, 315:1875-1888. 10.1016/j.yexcr.2009.03.010, 2742412, 19327352.
32. Hegmans JP, Bard MP, Hemmes A, Luider TM, Kleijmeer MJ, Prins JB, Zitvogel L, Burgers SA, Hoogsteden HC, Lambrecht BN. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am J Pathol 2004, 164:1807-1815. 10.1016/S0002-9440(10)63739-X, 1615654, 15111327.
33. Cho JA, Park H, Lim EH, Lee KW. Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells. Int J Oncol 2012, 40:130-138.
34. Arias AM. Epithelial mesenchymal interactions in cancer and development. Cell 2001, 105:425-431. 10.1016/S0092-8674(01)00365-8, 11371340.
35. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454. 10.1038/nrc822, 12189386.